Contact: Karen Stamm
|Peter Ravdin, M.D., Ph.D., has returned to the UT Health Science Center San Antonio to lead the Breast Health Clinic, part of the Cancer Therapy & Research Center at the UT Health Science Center San Antonio. |
Printer Friendly Format
, (210) 450-2020
On Monday, May 24, faculty, staff and the public will be invited to tour the Breast Health Clinic at the Cancer Therapy & Research Center (CTRC) of The University of Texas Health Science Center and to meet its recently hired director and expanded faculty.
More than two dozen physicians and scientists comprise the multidisciplinary team that will be on hand for the open house and reception from 5:30 p.m. to 7:30 p.m. in the sixth-floor clinic of the Zeller Building.
Though the CTRC physically completed the comprehensive breast clinic in late 2006, it has continued to add faculty and services. In March 2010, Peter Ravdin, M.D., Ph.D., was recruited to serve as program leader. It is a homecoming for the physician, researcher and administrator, who served on the Health Science Center’s medical oncology faculty from 1987 until 2003.
“I am very pleased to be rejoining the UT Health Science Center and CTRC,” said Dr. Ravdin. “This is a superb environment to deliver the best in cancer care and advance the state of the art. With all the specialties that are part of delivering breast cancer care, we have technically excellent and compassionate physicians. We are also part of the a fertile environment with one the country’s best programs for developing new treatments, and world-class basic scientists whose work has implications for the future of cancer prevention and treatment.” New clinic director is renown breast cancer researcher
During his first 16 years at the Health Science Center, Dr. Ravdin led major clinical trials, such as the one leading to Food and Drug Administration approval of Taxotere for breast cancer treatment. From 1997 to 1998, he was the CTRC’s chief of staff, followed by four years as an executive officer of the Southwest Oncology Group, one of the largest National Cancer Institute-funded cancer clinical trials cooperative groups in the U.S., whose operations office is in San Antonio.
In 2003, Dr. Ravdin began working independently and created a computerized decision-making tool called “Adjuvant!” He says the program has helped tens of thousands of physicians estimate a woman’s risk of relapse after breast cancer surgery. The tool enables a doctor and patient to make an informed decision about whether the benefits outweigh the risks of post-surgery chemotherapy or hormone therapy. Dr. Ravdin also served on the faculty of The University of Texas M. D. Anderson Cancer Center in Houston, where he studied hormone replacement therapy in postmenopausal women and its effect on breast cancer risk.
Additional new faculty members at the Breast Health Clinic
|More than two dozen professionals from a variety of disciplines comprise the Breast Health Clinic team. Shown, flanking Breast Health Clinic Director Peter Ravdin, M.D., Ph.D., (center, with beige slacks and blue tie) are health care professionals specializing in basic science, genetics, medical oncology, patient education and wellness, pathology, prevention research, psychosocial oncology, radiation oncology, radiology screening, and surgical oncology.|
The breast health team to be introduced at the May 24 open house includes three recently hired surgical oncologists who join veteran surgeon Anatolio B. Cruz, Jr., M.D., professor emeritus of surgical oncology. Ismail Jatoi, M.D., Ph.D., professor and chief of surgical oncology, is highly respected for his work in the U.S. and the U.K. He is joined by Alfredo Santillan, M.D., clinical assistant professor of surgery, and Boyce B. Oliver, Jr., M.D., clinical assistant professor of surgery. $1 million gift from the Cancer Center Council
During a brief program at 6 p.m., CTRC Executive Director Ian M. Thompson Jr., M.D., will announce a new pledge of $1 million to establish the Cancer Center Council Distinguished Chair in Oncology. He also will thank the volunteer council for paying in full its pledge of $750,000 that created the Patient Education Suite in the CTRC’s Breast Health Clinic.
Founded in 1984, the Cancer Center Council is a broad-based, nonprofit organization of more than 600 volunteers who have donated more than $2.4 million to the CTRC as well as provided cancer education programs, community outreach and patient assistance.###The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio
is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI)-designated Cancer Center, and is one of only three in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net